MedTrace Logo

Pharmacodynamic Comparison of Truncal Blocks in Patients With or Without Metabolic Disease (Kidney Failure, Diabetes)

NCT01323075 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-11-17

No results posted yet for this study

Summary

The primary objective is to demonstrate a longer period of neurologic recovery from a sensory block assessed in each test group versus the group without metabolic disease.

Conditions

Interventions

PROCEDURE

Truncal block

Patients will have a truncal block during hand or wrist surgery.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Philippe Cuvillon, MD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2013-12-13
Completion
2013-12-13

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01323075 on ClinicalTrials.gov